Intracavernosal administration of autologous ADRC
RU-CCH-01-01-15
Phase 2 other completed
Quick answer
Intracavernosal administration of autologous ADRC for Erectile Dysfunction is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Erectile Dysfunction
- Phase
- Phase 2
- Modality
- other
- Status
- completed